76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Bio-Rad Laboratories Inc
Closed
SectorHealthcare
256.75 -1.42
Overview
Share price change
24h
Min
253.5
Max
259.15
Income | 780M 64M |
|---|---|
Sales | -82M 585M |
EPS | 2.54 |
Profit margin | 10.933 |
Employees | 7,700 |
EBITDA | 75M 134M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +17.44% upside |
Next Earnings | 31 Jul 2025 |
|---|
Market Cap | 232M 6.8B |
|---|---|
Previous open | 258.17 |
Previous close | 256.75 |
News Sentiment
By Acuity
100%
0%
363 / 376 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Bio-Rad Laboratories Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bio-Rad Laboratories Inc Forecast
Price Target
By TipRanks
17.44% upside
12 Months Forecast
Average 305.2 USD 17.44%
High 387 USD
Low 234 USD
Based on 5 Wall Street analysts offering 12 month price targets forBio-Rad Laboratories Inc - Dist in the last 3 months.
Sentiment
By Acuity
363 / 376 Healthcare
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
